Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Country / region: Spain Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20131
20141
20152
20162
20172
20185
20194
20201
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
QED Therapeutics, a BridgeBio company3
Alexion Pharmaceuticals, Inc.2
BioMarin Pharmaceutical2
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Pfizer2
Swedish Orphan Biovitrum2
Fundació Sant Joan de Déu1
GenSight Biologics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn26
Blood Coagulation Disorders5
Coagulation Protein Disorders5
Hematologic Diseases5
Hemorrhagic Disorders5
Musculoskeletal Diseases5
Achondroplasia4
Bone Diseases4
Dwarfism4
Hemophilia A4

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.